Aplastic anemia can be mild, moderate, or severe. Mild or moderate aplastic anemia is serious but usually doesn't require hospitalization and may be treated with Blood transfusions and/or medications ...

Omidubicel is a nicotinamide modified unrelated allogeneic hematopoietic progenitor cell therapy derived from cord blood.

Experts provide an update regarding current understanding and management of aplastic anemia in a new review. 1 Eliska Furlong, MD, PhD, with the Perth Children’s Hospital, in Australia, and colleague ...

Severe Aplastic Anemia is a rare, life-threatening hematologic disorder in which the bone marrow fails to produce sufficient blood cells. Stem cell transplantation offers a potential cure; however, ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

Aplastic anemia in childhood is an uncommon but serious disorder, which affects ∼2 in 1 000 000 children each year. The majority of these cases are categorized as idiopathic because their primary ...

Some mutations in patients with aplastic anemia influence the response to therapy and long-term disease outcomes, according to a genomic cohort study by Tetsuichi Yoshizato, MD, from the Department of ...

Aplastic anemia, a rare condition, disrupts blood cell production due to bone marrow failure. It impacts patients physically and emotionally, requiring lifestyle changes and precautions to manage the ...

Aplastic anemia is a rare disorder characterized by inadequate production of blood cells by the bone marrow. The bone marrow is a spongy tissue inside the bones, where all the blood cells (red blood ...